A dopamine-precursor-based nanoprodrug for in-situ drug release and treatment of acute liver failure by inhibiting NLRP3 inflammasome and facilitating liver regeneration
- Resource Type
- Article
- Source
- In
Biomaterials January 2021 268 - Subject
- Language
- ISSN
- 0142-9612